2014 Prostate Cancer Research Highlights
- Crossing Barriers with an Enhanced Drug Delivery System for Prostate Cancer Therapy
- Treatment for Castrate-Resistant Prostate Cancer by Antagonists to the Androgen Receptor N-Terminal Domain
- Multi-dimensional magnetic resonance spectroscopy technique for improved Prostate Cancer detection and diagnosis via metabolic profiling
- Theranostic nanoparticles: Improved imaging agents capable of reporting on the site specific delivery of therapeutics to prostate cancer cells
- Synergism of Docetaxel with Androgen Ablation Therapy in Prostate Cancer
- Discovery of a Single Genetic Mutation in Castration-Resistant Prostate Cancer Could Lead to New Biomarkers and Targeted Therapies
- Novel Hyperpolarized Molecular Imaging Biomarkers for Prostate Cancer
- Reprogramming Prostate Cancer Cells to Normal Prostate Cells
- Nowhere to Hide: Better Non-invasive Detection of Prostate Cancer Using Improved Imaging
- Reduction of Zinc Levels as a Novel Mechanism for Prostate Cancer Therapy
- Optical Sensing of Microscopic Structures May Be Used to Grade Prostate Cancer and Predict Patient Outcome
- Predicting Prostate Cancer Recurrence - Using Biomarkers to Guide Treatment Decision Making
- A Newly Developed Therapeutic Antibody That Induces Immunity to Prostate Cancer
- Polycomb Gene BMI1 as a Promising Target in Prostate Cancer Chemoresistance
- Circulating Tumor Cells as Better Predictors of Response to Prostate Cancer Treatment
- Attacking Androgen-Insensitive Prostate Cancer from a New Angle